Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis

Status Completed

Clinical Trial Summary

Immunoglobulin G4-related disease (IgG4-RD) is an uncommon inflammatory disorder that may affect multiple organ systems, including the biliary tree. IgG4-sclerosing cholangitis (IgG4-SC) can be difficult to distinguish from primary sclerosing cholangitis (PSC) or cholangiocarcinoma (CCA). The investigators aim to evaluate the sensitivity and specificity of bile for the diagnosis of IgG4-SC. Bile samples of patients with biliary strictures of various causes, including IgG4-SC, PSC, and CCA, will be collected during clinical cholangiography procedures. IgG4 will be measured in bile specimens and bile IgG4 concentrations compared between IgG4-SC, PSC, CCA, and other types of biliary strictures.

Clinical Trial Description

This study will recruit cases from Mayo Clinic Rochester and Japanese institutions such as Nagoya City University Hospital, Nagoya Daini Red Cross Hospital, and Kurashiki Central hospital. Participants will be individuals who will receive endoscopic retrograde cholangiography (ERC), endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) or percutaneous transhepatic cholangiography (PTC). Bile samples collected from the target cases will be assayed for IgG4 concentration. ;

Study Design

Related Conditions & MeSH terms

Cholangitis
Cholangitis, Sclerosing
IgG4-related Disease
IgG4-related Sclerosing Cholangitis

Clinical Trial Details

NCT number	NCT02616705
Study type	Observational
Source	Mayo Clinic
Contact
Status	Completed
Phase
Start date	November 2015
Completion date	September 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03368274` - To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom	Phase 4
Not yet recruiting	`NCT03267875` - A Laboratory Scan of Patients With Aortic Aneurysms to IgG4 Levels in the Blood	N/A
Completed	`NCT03669861` - Safety and Efficacy of Abatacept in IgG4-Related Disease	Phase 2
Recruiting	`NCT05625581` - Tofatib Treatment for IgG4-related Disease
Recruiting	`NCT04125511` - Characterizing IgG4-RD With 68Ga-FAPI PET/CT	Early Phase 1
Not yet recruiting	`NCT06285539` - Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases	Phase 2
Not yet recruiting	`NCT05746689` - Study of Sirolimus in IgG4-related Disease	N/A
Completed	`NCT03690908` - Infraorbital Nerve Involvement on Magnetic Resonance Imaging in IgG4-related Ophthalmic Disease
Completed	`NCT02899039` - Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease	N/A
Recruiting	`NCT04660565` - Belimumab Treatment for IgG4-related Disease	Phase 4
Recruiting	`NCT01670695` - A Prospective Cohort Study of IgG4RD in China	N/A
Recruiting	`NCT03023371` - National Registry of IgG4-RD in China	N/A
Unknown status	`NCT01758393` - Glucocorticoids in Patients With IgG4-RD	Phase 2/Phase 3
Completed	`NCT02705638` - Treatment of IgG4-Related Disease With Revlimid and Rituximab	Phase 1
Recruiting	`NCT03473912` - Meir Medical Center Rheumatologic Biobank
Not yet recruiting	`NCT03466970` - Plasmablast Detection From IgG4-Related Disease Patients	N/A